VELORA BIOLABS · Batch Verification

Batch Verification

✓ Verified Batch

Semax 10 mg

Lot VBL-SX10-1
✓ Independently verified by ILS Laboratories

This batch was independently verified by an ISO/IEC 17025-accredited laboratory for identity, purity, and safety.

Identity
✓ Confirmed
Purity
98.16%
Endotoxin
PASS
NMT 0.05 EU/mL
Fentanyl
Not Detected
View Laboratory Verification →
Verify Directly with ILS Laboratories →

Independent laboratory verification. Supplements — does not replace — the Velora portal and laboratory report.

Laboratory Information
Testing Laboratory
ILS Laboratories (ISO/IEC 17025 accredited)
Source COA Number
COA-2026-KVH0S0
Analysis Date
2026-09-09
Analytical Methods
Purity, Identity & Quantitation (HPLC), Endotoxin (USP <85>)
Independent Verification

This report can be confirmed directly with the testing laboratory.

Verify Directly with ILS Laboratories →
Technical Data
Net Peptide Content
10.35 mg
Appearance
Good
Methodology
Peptide purity determined by RP-HPLC area normalization at 214 nm. Value represents the percentage of the target peptide relative to all peptide-related peaks. Non-peptide process-related impurities, if detected, are excluded from the calculation.
Technical Notes
Sample confirmed to be Semax by HPLC (identification by chromatographic retention-time comparison with a reference standard). Endotoxin tested per USP <85> kinetic chromogenic method; acceptance criteria NMT 5 EU/mL per client specification. Fentanyl screen: immunoassay, 50 ng/mL cutoff, Not Detected.

Research Use Only (RUO). Verification reflects the analyzed batch identified above.